Prostate-Specific Antigen (PSA) Testing Market Share, Trends, and Analysis by 2031
Prostate-Specific Antigen (PSA) Testing Market Report Analysis
Prostate-Specific Antigen (PSA) Testing Market
-
CAGR (2025 - 2031)XX% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Abbott Laboratories Inc
- AstraZeneca plc
- Bayer AG
- Beckman Coulter Inc
- Bristol
- Myers Squibb Company
- GE Healthcare
- GlaxoSmithKline plc
- Merck Co Inc
Regional Overview

- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation

- Total Prostate Specific Antigen Test
- Complex Prostate Specific Antigen Test
- Free Prostate Specific Antigen Test
- Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test
- PCA3Test
- Trans-rectal Ultrasound
- Biopsy

- Radioimmunoassay
- Enzyme Immunoassay